Publications by Xindan Meng

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=Xindan+Meng%5Bauthor%5D&datetype=edat&usehistory=y&retmax=1&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&WebEnv=MCID_67957a829a8a2ffed20b8942&query_key=1&retmode=xml&retstart=-10&retmax=25&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 Publications by Xindan Meng | LitMetric

Publications by authors named "Xindan Meng"

Page 1 of 1

The modulation of cAMP/PKA pathway by asiaticoside ameliorates high glucose-induced inflammation and apoptosis of retinal pigment epithelial cells.

Yixia Zhang Xindan Meng Keyu Liu

J Bioenerg Biomembr

February 2022

Asiaticoside, the major bioactive constituent purified from Centella asiatica, is a pentacyclic triterpene saponin with sugar moieties (glucose-glucose-rhamnose). Its biological activities including anti-inflammation and antioxidant have been widely reported. This study aimed to investigate the role of asiaticoside in diabetic retinopathy (DR).

View Article and Find Full Text PDF